Centyl med kaliumchlorid

Centyl is a well-established pharmaceutical brand primarily used as a diuretic medication. The brand was originally developed by the Danish pharmaceutical giant LEO Pharma. It is commonly prescribed for conditions like hypertension or edema, often combined with potassium chloride (kaliumchlorid) as seen in this version to maintain electrolyte balance.

Manufacturing for LEO Pharma products is distributed across various international sites, with a significant production hub located in Ireland, though global supply chains mean it may be sourced from several EU locations.

In terms of ownership, Centyl remains part of the LEO Pharma portfolio. As of the current trajectory, LEO Pharma transitioned from being exclusively foundation-owned to having a majority of its shares controlled by Nordic Capital since 2021, while the LEO Foundation remains a significant long-term owner to support the company’s dermatological and medical research focus.